Sirolimus in pediatric solid organ transplantation

Pediatric Transplantation

Volumn 9, Issue 4, 2005, Pages 427-429

  Dharnidharka, Vikas R ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ABDOMINAL PAIN; ADOLESCENT; CHILD; DRUG ACTIVITY; DRUG EFFICACY; DRUG INDICATION; DRUG POTENCY; DRUG TARGETING; EDITORIAL; EPSTEIN BARR VIRUS; GRAFT SURVIVAL; HEPATOBLASTOMA; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFECTION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCELE; MOUTH ULCER; NEPHROTOXICITY; NONHUMAN; ORGAN TRANSPLANTATION; PROTEINURIA; SMOOTH MUSCLE; TREATMENT OUTCOME; WOUND DEHISCENCE; WOUND HEALING;

CHILD; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; SIROLIMUS;

EID: 23844457596     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00385.x     Document Type: Editorial

References (17)

1. SEHGAL SN. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 1998: 31: 335-340.
2. MARX SO, JAYARAMAN T, GO LO, MARKS AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 1995: 76: 412-417.
3. MORALES JM, WRAMNER L, KREIS H, et al. Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients. Am J Transplant 2002: 2: 436-442.
4. GROTH CG, BACKMAN L, MORALES JM, et al. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation 1999: 67: 1036-1042.
5. KAHAN BD. Sirolimus-based immunosuppression: present state of the art. J Nephrol 2004; 17(Suppl. 8): S32-S39.
6. NEPOMUCENO RR, BALATONI CE, NATKUNAM Y, SNOW AL, KRAMS SM, MARTINEZ OM. Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein-Barr virus B-cell lymphomas. Cancer Res 2003: 63: 4472-4480.
7. MAJEWSKI M, KORECKA M, KOSSEV P, et al. The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: a potential approach to prevention and treatment of posttransplant lymphoproliferative disorders. Proc Natl Acad Sci USA 2000: 97: 4285-4290.
8. DHARNIDHARKA VR, TEJANI AH, HO PL, HARMON WE. Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk. Am J Transplant 2002: 2: 993-998.
9. HYMES LC, WARSHAW BL. Sirolimus in pediatric patients: results in the first six months post-renal transplant. Pediatr Transplant 2005: 9: 520-522.
10. JIMENEZ-RIVERA C, AVITZUR Y, FECTEAU AH, JONES N, GRANT D, NG VL. Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma. Pediatr Transplant 2004: 8: 243-248.
11. LOBACH NE, POLLOCK-BARZIV SM, WEST LJ, DIPCHAND AI. Sirolimus immunosuppression in pediatric heart transplant recipients: a single-center experience. J Heart Lung Transplant 2005: 24: 184-189.
12. VESTER U, KRANZ B, NADALIN S, PAUL A, BECKER J, HOYER PF. Sirolimus rescue of renal failure in children after combined liver-kidney transplantation. Pediatr Nephrol 2005: 20: 686-689.
13. BUTANI L. Investigation of pediatric renal transplant recipients with heavy proteinuria after sirolimus rescue. Transplantation 2004: 78: 1362-1366.
14. LANGER RM, KAHAN BD. Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients. Transplantation 2002: 74: 804-808.
15. GUILBEAU JM. Delayed wound healing with sirolimus after liver transplant. Ann Pharmacother 2002: 36: 1391-1395.
16. KING-BIGGS MB, DUNITZ JM, PARK SJ, KAY SAVIK S, HERTZ MI. Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. Transplantation 2003: 75: 1437-1443.
17. KAHAN BD. The potential role of rapamycin in pediatric transplantation as observed from adult studies. Pediatr Transplant 1999: 3: 175-180.